Alan C. Cheng
Affiliations: | Brandeis University, Waltham, MA, United States |
Google:
"Alan Cheng"Mean distance: (not calculated yet)
Parents
Sign in to add mentorAlan D. Frankel | grad student | 2002 | UCSF | |
(Strategies for specific recognition of RNA using hydrogen bonding.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cheng AC, Doherty EM, Johnstone S, et al. (2019) Structure-guided discovery of dual recognition chemibodies Acta Crystallographica Section A. 75 |
Cheng AC, Doherty EM, Johnstone S, et al. (2018) Structure-guided Discovery of Dual-recognition Chemibodies. Scientific Reports. 8: 7570 |
Loving KA, Lin A, Cheng AC. (2014) Structure-based druggability assessment of the mammalian structural proteome with inclusion of light protein flexibility. Plos Computational Biology. 10: e1003741 |
Gustin DJ, Li Y, Brown ML, et al. (2013) Structure guided design of a series of sphingosine kinase (SphK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 4608-16 |
Huang H, La DS, Cheng AC, et al. (2012) Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease. Journal of Medicinal Chemistry. 55: 9156-69 |
Bryan MC, Whittington DA, Doherty EM, et al. (2012) Rapid development of piperidine carboxamides as potent and selective anaplastic lymphoma kinase inhibitors. Journal of Medicinal Chemistry. 55: 1698-705 |
Liu JJ, Cheng AC, Tang HL, et al. (2011) Benzodiazepinone Derivatives as CRTH2 Antagonists. Acs Medicinal Chemistry Letters. 2: 515-8 |
Schenkel LB, Huang X, Cheng A, et al. (2011) Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors. Journal of Medicinal Chemistry. 54: 8440-50 |
Peterson ML, Stanton MK, Kelly RC, et al. (2011) Preparation, solid state characterization, and single crystal structure analysis of N-(4-(6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yloxy)benzo[d] thiazol-2-yl)acetamide crystal forms Crystengcomm. 13: 1170-1180 |
Cee VJ, Schenkel LB, Hodous BL, et al. (2010) Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor. Journal of Medicinal Chemistry. 53: 6368-77 |